D
Daniel Aletaha
Researcher at Medical University of Vienna
Publications - 398
Citations - 51111
Daniel Aletaha is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Rheumatoid arthritis & Medicine. The author has an hindex of 74, co-authored 298 publications receiving 43215 citations. Previous affiliations of Daniel Aletaha include National Institutes of Health & University of Vienna.
Papers
More filters
Journal ArticleDOI
New therapies for treatment of rheumatoid arthritis
TL;DR: The targets of these drugs, the roles of these targets in the pathogenesis of rheumatoid arthritis, and the efficacy and adverse effects of these agents from clinical trial data are discussed.
Journal ArticleDOI
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
Daniel Aletaha,Valerie Nell,Tanja Stamm,Martin Uffmann,Stephan Pflugbeil,Klaus P Machold,Josef S Smolen +6 more
TL;DR: A purely clinical score is a valid measure of disease activity and will have its greatest merits in clinical practice rather than research, where APRs are usually always available.
Journal ArticleDOI
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
Laure Gossec,Josef S Smolen,Sofia Ramiro,M. de Wit,Maurizio Cutolo,Maxime Dougados,Paul Emery,Robert Landewé,Sue Oliver,Daniel Aletaha,Neil Betteridge,Jürgen Braun,G.-R. Burmester,Juan D. Cañete,Nemanja Damjanov,Oliver FitzGerald,Emma Haglund,P S Helliwell,Tore K Kvien,Rik Lories,Thomas A. Luger,Mara Maccarone,Helena Marzo-Ortega,Dennis McGonagle,Iain B. McInnes,I. Olivieri,Karel Pavelka,Georg Schett,Joachim Sieper,F. Van den Bosch,Douglas J. Veale,Jürgen Wollenhaupt,Angela Zink,D. van der Heijde +33 more
TL;DR: These recommendations provide stakeholders with an updated consensus on the pharmacological treatment of PsA and strategies to reach optimal outcomes in PsA, based on a combination of evidence and expert opinion.
Journal Article
The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis
Daniel Aletaha,Josef S Smolen +1 more
TL;DR: The Simplified Disease Activity Index (SDAI) and the Clinical Disease activity Index (CDAI), developed to provide physicians and patients with simple and more comprehensible instruments, are the only composite index that does not incorporate an acute phase response and can be used to conduct a disease activity evaluation essentially anytime and anywhere.
Journal ArticleDOI
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
George A. Wells,J-C Becker,Julie Teng,Maxime Dougados,Michael Schiff,Josef S. Smolen,Daniel Aletaha,P.L.C.M. van Riel +7 more
TL;DR: The Das28 (CRP) has been validated against radiographic progression and physical function and the validation profile was similar to the DAS28 (ESR), indicating that both measures are useful for assessing disease activity in patients with rheumatoid arthritis.